Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1998-4-9
pubmed:abstractText
Inhibition of protein synthesis may result in superinduction of short-lived transcripts and has been attributed variably to stabilization of transcripts and/or increased gene transcription. Little is known about the kinetics of these processes and relevant transcriptional elements have not been identified. In this study, we describe superinduction of interleukin 8 (IL-8) mRNA, an important inflammatory mediator, in lung epithelial-like H292 cells and identify the underlying molecular mechanisms and their kinetics. Cycloheximide (CHI, 10 microg/ml), an inhibitor of protein synthesis, maximally increased IL-8 mRNA levels 30-fold in H292 cells. Tumour necrosis factor alpha (TNF-alpha), which induced IL-8 mRNA 3-fold, synergized with CHI causing a 150-fold increase at 6 h. CHI early on increased the stability of IL-8 mRNA (from 40 min in cells cultured with medium to more than 4 h with CHI). CHI also increased transcription as shown by transfection with IL-8 promoter constructs. Truncated and mutated constructs identified NF-kappaB and AP-1 binding sites as primary cis-acting elements in IL-8 gene transcription and IL-8 mRNA superinduction. Electrophoretic mobility shift assays indicated that CHI increased NF-kappaB and prolonged AP-1 DNA-binding activities and that the synergism of TNF-alpha and CHI on IL-8 mRNA expression was paralleled by a further increase of AP-1 DNA-binding activity. This synergism was still noticed when 4 h elapsed between the addition of CHI and that of TNF-alpha. Taken together, our results indicate that CHI interferes with both post-transcriptional and transcriptional repressive mechanisms of IL-8 mRNA expression.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-1179208, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-1331059, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-1497091, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-1628615, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-1856209, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-2250017, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-2431274, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-25275, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-270686, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-2739725, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-2771659, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-3276786, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-3615200, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-419694, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-6330726, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-685176, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-7526704, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-7651411, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-7713192, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-7739549, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-7935449, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-8057934, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-8096514, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-8175759, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-8207232, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-8304236, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-8413306, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-8473010, http://linkedlifedata.com/resource/pubmed/commentcorrection/9461540-8561789
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
330 ( Pt 1)
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
429-35
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
Enhanced AP-1 and NF-kappaB activities and stability of interleukin 8 (IL-8) transcripts are implicated in IL-8 mRNA superinduction in lung epithelial H292 cells.
pubmed:affiliation
Department of Pulmonology, Academic Medical Centre, Meibergdreef 9, P.O. Box 22700, 110 DE Amsterdam, The Netherlands.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't